The latest Medical Devices & Services Patent Scorecard™ was released today and has ranked 126 of the top Medical Devices & Services companies according to the relative strengths of their patent portfolios as measured by Technology Strength™. The Patent Scorecard™ provides an overall assessment of a company’s recent intellectual property quality and quantity at a broad industry level. The Patent Board tracks seventeen industry scorecards and also creates customized scorecards that provide insight with leading performance indicators for an entire portfolio and its closest competitors, scalable at the technology or business unit level.
Medtronic Inc. (Minneapolis, Minnesota, USA) regains the top spot in the Patent Scorecard™ this quarter, for the first time in a year. The company had patent growth of almost 20%, well above the industry average increase of 11%. Medtronic turned in a stellar performance, with a Science Strength™ increase of 80%, an Industry Impact™ improvement of 29%, a Research Intensity™ increase of 28%, and an overall Technology Strength™ increase of 53%.
The 2nd place company, Covidien Plc (Dublin, Ireland) had patent growth that kept up with the industry average, but loses the #1 spot. The company’s Industry Impact™ decreased by over 8%, and while it posted a 31% increase in Science Strength™ indicating how much a company uses science in building its patent portfolio, all other indicators were flat for the quarter. Johnson & Johnson (New Brunswick, New Jersey, USA) moves up one spot to 3rd, with strong increases in almost every indicator for the quarter. Patent growth was up 20%, Science Strength™ increased 23%, Industry Impact™ improved over 16%, and overall Technology Strength™ was up 38%. The company did show a 19% increase in Research Intensity™, but still lags 20% behind the industry average in this indicator.
For the complete press release please email: cwren@patentboard.com
Return
